| Pain Management |
1 |
1 |
| Wound Management |
0 |
0.95 |
| Edema |
0 |
0.99 |
| Hypertension |
0 |
0.86 |
| Biliary Disease |
0 |
0.79 |
| Heart Failure (HF) |
0 |
0.34 |
| Diabetic Microvascular Complications |
0 |
0.28 |
| Thromboembolism |
0 |
0.28 |
| Thyroid Disease |
0 |
0.22 |
| Arrhythmia |
0 |
0.21 |
| Neuropathic Pain |
0 |
0.2 |
| Patient Safety |
0 |
0.19 |
| Capillary |
0 |
0.18 |
| Pain |
0 |
0.18 |
| Obesity |
0 |
0.17 |
| Renal Failure |
0 |
0.17 |
| Deep Venous Thrombosis |
0 |
0.14 |
| Receptors |
0 |
0.14 |
| Angiotensin II Receptor Blockade |
0 |
0.13 |
| ACE Inhibitor |
0 |
0.11 |
| Diuretics |
0 |
0.11 |
| Lymphedema |
0 |
0.11 |
| Renal Disease |
0 |
0.11 |
| Amyloidosis |
0 |
0.1 |
| Diabetic Nephropathy |
0 |
0.1 |
| Healthcare and Medical Technology |
0 |
0.1 |
| Osteoarthritis |
0 |
0.1 |
| Systemic Lupus Erythematosus |
0 |
0.1 |
| Nonsteroidal Anti-Inflammatory Agents |
0 |
0.09 |
| Adverse Effects |
0 |
0.07 |
| Cirrhosis |
0 |
0.07 |
| Hyperglycemia |
0 |
0.07 |
| Steroids |
0 |
0.07 |